Related Experiment Videos

Phosphorylation of microsomal HMG CoA reductase increases susceptibility to proteolytic degradation in vitro

Insights

Rat liver calpain-II protease converts native HMG CoA reductase into smaller, active forms. Pretreatment with ATP and liver reductase kinase enhances this conversion, increasing soluble enzyme activity.

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • HMG CoA reductase is a key enzyme in cholesterol biosynthesis.
  • The enzyme exists in different forms, including native microsomal and soluble active forms.
  • Proteolytic cleavage is implicated in regulating enzyme activity.

Purpose of the Study:

  • To investigate the in vitro conversion of native rat liver HMG CoA reductase.
  • To identify the protease responsible for cleaving HMG CoA reductase.
  • To determine the effect of enzyme modification on cleavage.

Main Methods:

  • Purification of calpain-II protease from rat liver cytosol.
  • In vitro enzymatic assays using purified HMG CoA reductase and calpain-II.
  • Microsomal pretreatment with ATP(Mg2+) and liver reductase kinase or protein phosphatase.
  • Analysis of enzyme forms by SDS-PAGE and immunoblotting.

Main Results:

  • Calpain-II catalyzed the conversion of native 97-100 kDa HMG CoA reductase to membrane-bound 62 kDa and soluble 52-56 kDa forms.
  • Pretreatment of microsomes with ATP(Mg2+) and liver reductase kinase enhanced reductase cleavage.
  • Enhanced cleavage resulted in decreased 97-100 kDa species and increased soluble 52-56 kDa species.

Conclusions:

  • Calpain-II is a key protease involved in the conversion of HMG CoA reductase.
  • Enzyme inactivation via phosphorylation enhances proteolytic cleavage by calpain-II.
  • This process generates catalytically active soluble forms of HMG CoA reductase.

Related Concept Videos